Both in Pharmaceuticals
Spyre Therapeutics vs Protagonist Therapeutics
Over the past year SYRE returned +301.6% and PTGX returned +83.5%; their daily moves had a correlation of 0.37.
SYRE +301.6% PTGX +83.5%Growth of $1, one year, split-adjusted
| Metric | SYRE | PTGX |
|---|---|---|
| Price | $95.51 | $139.37 |
| Market cap | $8.93B | $9.02B |
| Today | −1.09% | −3.78% |
| 1 month | +2.5% | −0.5% |
| 6 months | +38.2% | +40.0% |
| Year to date | +191.5% | +59.6% |
| 1 year | +293.7% | +79.0% |
| Revenue growth (YoY) | — | +3749.2% |
| Gross margin | — | 100.0% |
| Net margin | — | 76.3% |
| P/E (TTM) | — | 108.8× |
| Price / sales | — | 32.0× |
| Net cash | $1.15B | $782.6M |
| Dividend yield | — | — |
| Volatility (60d) | 58.6% | 32.2% |
| Short % of float | 15.6% | 16.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).